The blog
Clinical trial results, TGA regulatory progress and research updates on retatrutide and the wider peptide space — explained for Australians.
13 September 2026 · bpc-157 · peptide research · tga · clinical trials
BPC-157 research did reach human trials once - a Pliva ulcerative colitis study never published in a journal. What that means, plus its legal status in Australia.
Read more →10 September 2026 · bpc-157 · peptides · research · australia · regulation
BPC-157 clears the blood in under 30 minutes but is credited with effects lasting days. What the PK data, a 2026 review and Australia's TGA rules say.
Read more →27 August 2026 · bpc-157 · peptides · healing · tga
BPC-157 is hugely popular but barely tested in humans. What the animal studies show, why the TGA made it prescription-only, and where WADA and the FDA stand.
Read more →Stay informed
Retatrutide is not yet available to the public. But when it is, you will want to be first to know. Sign up to receive:
Get the free guide + updates
Enter your details once on our free access guide page — instant download, plus we'll email you the moment there's real news.